CUDIS
CUDIS - # 411 ActiveGobal Asset
-
Rating Score 63.27Rating Grade B
- Rating Version APYWA-v1.1 / Rating Date 2025-12-22
Overview
CUDIS is a global longevity incentive protocol designed for everyone, powered by real human data. Through the CUDIS Ring, a smart ring–type wearable device, and a blockchain-based mobile application, users retain self-sovereignty over their health data while receiving real-time longevity insights and economic rewards for data contribution. CUDIS is the native utility token of the ecosystem and is used for governance and service-related purposes, enabling holders to participate in key decision-making processes and to access health-related services within the ecosystem in the future.
Metric Radar Chart
Metric Bar Chart
Metric Trends
| Total Rating Score | TNNeutral |
|---|---|
| Market Accessibility | TNNeutral |
| Development Activity | TNNeutral |
| Market Liquidity | TNNeutral |
| Community Engagement | TNNeutral |
| Risk & Security | TL2Gradual Downtrend |
Total Rating Score Trend
Market Data
- Token Price $0.028451 (↘2.34%)
- Volume (24h) $6.05M (↘12.53%)
- Market Cap $7.04M (↗7.19%)
-
Circulating Supply
247,500,000 CUDIS
247,500,000 CUDIS
(Source : Coinmarketcap , Coingecko )
Listed Exchanges
- Korean
-
- Global
-
×
View All Exchanges
- Korean
-
- Global
-
Community Info
X (Twitter) Tweets (Last 30 Days)
105 (-9)
Development Info
- GitHub Account -
-
Stars
- (-)
- Commits (Last 3 Months) - (-)
Security Audit Info
- Security Audit Status None
- CertiK Code Security Score 54 pts
(Source : Coinmarketcap , CertiK Skynet )
Issue Info
- Trading History
- 2025.09.26 [빗썸] 거래소에 신규 거래 지원됩니다.
- Risk History
- No records found
View Full History
| Category | Date | Exchange | Link | Grade | Details |
|---|---|---|---|---|---|
| Regular Evaluation | 2025-12-22 | - | - | B(63.27) | [AW-0119-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-12-18 | - | - | B(63.27) | [AW-0118-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-12-15 | - | - | B(64.17) | [AW-0117-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-12-11 | - | - | B(64.77) | [AW-0116-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-12-08 | - | - | B(64.52) | [AW-0115-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-12-04 | - | - | B(66.17) | [AW-0114-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-12-01 | - | - | B(65.21) | [AW-0113-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-11-27 | - | - | B(66.33) | [AW-0112-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-11-24 | - | - | B(64.77) | [AW-0111-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-11-20 | - | - | B(65.93) | [AW-0110-정기] 평가가 완료되었습니다. |
- Disclaimer
-
The ratings provided by APYWA (hereinafter 'the Company') are conducted via an automated system based on public data and are pure data-driven analysis results with no subjective elements. This rating material includes evaluations on five key metrics: Market Accessibility, Development Activity, Market Liquidity, Community Engagement, and Security. All information provided is for reference purposes only.
Our ratings are not intended as investment advice or recommendations, and we do not guarantee the accuracy, completeness, or timeliness of the information. Users must make their own investment decisions based on the provided data, and the Company bears no legal liability for any resulting losses or damages.
While the rating material is processed automatically based on reliable data, discrepancies with actual market conditions may occur due to data limitations. Therefore, the Company is not liable for any damages arising from the use of the provided information. All information contained herein is the property of the Company and may not be reproduced, distributed, or modified without prior approval.